TY - JOUR
T1 - Relationship of early-onset baldness to prostate cancer in african-american men
AU - Zeigler-Johnson, Charnita
AU - Morales, Knashawn H.
AU - Spangler, Elaine
AU - Chang, Bao Li
AU - Rebbeck, Timothy R.
PY - 2013/4
Y1 - 2013/4
N2 - Background: Early-onset baldness has been linked to prostate cancer; however, little is known about this relationship in AfricanAmericans who are at elevated prostate cancer risk. Methods: We recruited 219 African-American controls and 318 African-American prostate cancer cases. We determined age-stratified associations of baldness with prostate cancer occurrence and severity defined by high stage (T3/T4) or high grade (Gleason 7+.) Associations of androgen metabolism genotypes (CYP3A4, CYP3A5, CYP3A43, AR-CAG, SRD5A2 A49T, and SRD5A2 V89L), family history, alcohol intake, and smoking were examined by baldness status and age group by using multivariable logistic regression models. Results: Baldness was associated with odds of prostate cancer [OR 1.69; 95% confidence interval (CI), 1.05- 2.74]. Frontal baldness was associated with high-stage (OR 2.61; 95% CI, 1.10-6.18) and high-grade (OR 2.20; 95% CI, 1.05-4.61) tumors. Formendiagnosed less than the age of 60 years, frontal baldness was associated with high stage (OR 6.51; 95% CI, 2.11-20.06) and high grade (OR 4.23; 95% CI, 1.47-12.14). We also observed a suggestion of an interaction among smoking, median age, and any baldness (P 0.02). Conclusions: We observed significant associations between early-onset baldness and prostate cancer in African-American men. Interactions with age and smoking were suggested in these associations. Studies are needed to investigate the mechanisms influencing the relationship between baldness and prostate cancer in African-American men. Impact: African-American men present with unique risk factors including baldness patterns that may contribute to prostate cancer disparities.
AB - Background: Early-onset baldness has been linked to prostate cancer; however, little is known about this relationship in AfricanAmericans who are at elevated prostate cancer risk. Methods: We recruited 219 African-American controls and 318 African-American prostate cancer cases. We determined age-stratified associations of baldness with prostate cancer occurrence and severity defined by high stage (T3/T4) or high grade (Gleason 7+.) Associations of androgen metabolism genotypes (CYP3A4, CYP3A5, CYP3A43, AR-CAG, SRD5A2 A49T, and SRD5A2 V89L), family history, alcohol intake, and smoking were examined by baldness status and age group by using multivariable logistic regression models. Results: Baldness was associated with odds of prostate cancer [OR 1.69; 95% confidence interval (CI), 1.05- 2.74]. Frontal baldness was associated with high-stage (OR 2.61; 95% CI, 1.10-6.18) and high-grade (OR 2.20; 95% CI, 1.05-4.61) tumors. Formendiagnosed less than the age of 60 years, frontal baldness was associated with high stage (OR 6.51; 95% CI, 2.11-20.06) and high grade (OR 4.23; 95% CI, 1.47-12.14). We also observed a suggestion of an interaction among smoking, median age, and any baldness (P 0.02). Conclusions: We observed significant associations between early-onset baldness and prostate cancer in African-American men. Interactions with age and smoking were suggested in these associations. Studies are needed to investigate the mechanisms influencing the relationship between baldness and prostate cancer in African-American men. Impact: African-American men present with unique risk factors including baldness patterns that may contribute to prostate cancer disparities.
UR - http://www.scopus.com/inward/record.url?scp=84876515014&partnerID=8YFLogxK
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=purepublist2023&SrcAuth=WosAPI&KeyUT=WOS:000317960900015&DestLinkType=FullRecord&DestApp=WOS
U2 - 10.1158/1055-9965.EPI-12-0944
DO - 10.1158/1055-9965.EPI-12-0944
M3 - Article
C2 - 23532004
SN - 1055-9965
VL - 22
SP - 589
EP - 596
JO - Cancer Epidemiology Biomarkers and Prevention
JF - Cancer Epidemiology Biomarkers and Prevention
IS - 4
ER -